Our Biosimilars Conference will encompass six scientific areas:
The future of next generation Biosimilars
EU legal guidelines & development strategies
Challenges for scientific researchers in drug, devices and biologics
Biosimilars clinical trials
Commercial opportunities & strategies to develop Biosimilars
Investment & potential returns from Biosimilars
Added by sabrina daw on April 27, 2011